Cstone Pharmaceuticals Stock Price Patterns
| CSPHF Stock | USD 0.70 0.02 2.78% |
Momentum 56
Buy Extended
Oversold | Overbought |
Using CStone Pharmaceuticals hype-based prediction, you can estimate the value of CStone Pharmaceuticals from the perspective of CStone Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CStone Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying CStone because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CStone Pharmaceuticals after-hype prediction price | USD 0.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CStone |
CStone Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of CStone Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CStone Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of CStone Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CStone Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting CStone Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CStone Pharmaceuticals' historical news coverage. CStone Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.03 and 4.90, respectively. We have considered CStone Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CStone Pharmaceuticals is abnormally volatile at this time. Analysis and calculation of next after-hype price of CStone Pharmaceuticals is based on 3 months time horizon.
CStone Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as CStone Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CStone Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CStone Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 4.20 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.70 | 0.70 | 0.00 |
|
CStone Pharmaceuticals Hype Timeline
CStone Pharmaceuticals is currently traded for 0.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. CStone is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.3%. %. The volatility of related hype on CStone Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.70. About 48.0% of the company shares are held by company insiders. The book value of CStone Pharmaceuticals was currently reported as 0.8. The company recorded a loss per share of 0.25. CStone Pharmaceuticals had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out CStone Pharmaceuticals Basic Forecasting Models to cross-verify your projections.CStone Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to CStone Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict CStone Pharmaceuticals' future price movements. Getting to know how CStone Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CStone Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CSBTF | Kuros Biosciences AG | 0.00 | 0 per month | 0.00 | (0.16) | 0.00 | 0.00 | 14.87 | |
| MEOBF | Mesoblast | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | 0.00 | 57.06 | |
| ASCLF | Ascletis Pharma | 0.00 | 0 per month | 3.63 | 0.14 | 13.14 | (4.69) | 52.45 | |
| PPTDF | PeptiDream | 0.00 | 0 per month | 0.00 | (0.05) | 5.00 | (6.15) | 20.35 | |
| PHMMF | Pharma Mar SAU | 0.00 | 0 per month | 0.00 | (0.15) | 0.00 | (0.12) | 7.16 | |
| ONTTF | Oxford Nanopore Technologies | 0.00 | 0 per month | 3.83 | 0.03 | 8.93 | (5.91) | 25.32 | |
| CHIZF | China Traditional Chinese | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SNBIF | SanBio Company Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RYHTY | Ryman Healthcare Ltd | 0.00 | 0 per month | 0.00 | (0.06) | 0.00 | 0.00 | 11.72 | |
| NURPF | Neuren Pharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.10) | 0.16 | (5.11) | 20.18 |
CStone Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine CStone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CStone using various technical indicators. When you analyze CStone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CStone Pharmaceuticals Predictive Indicators
The successful prediction of CStone Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CStone Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CStone Pharmaceuticals based on analysis of CStone Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CStone Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CStone Pharmaceuticals's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for CStone Pink Sheet analysis
When running CStone Pharmaceuticals' price analysis, check to measure CStone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CStone Pharmaceuticals is operating at the current time. Most of CStone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of CStone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CStone Pharmaceuticals' price. Additionally, you may evaluate how the addition of CStone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |